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ABSTRACT
Bacillary angiomatosis (BA) is an angioproliferative disease of immunocompromised 
patients that usually presents as vascular tumors in the skin and subcutaneous tissues. It is 
caused by chronic infections with either Bartonella henselae or B. quintana. Oral cavity BA 
is exceedingly rare and even rarer without simultaneous cutaneous disease. We report herein 
the case of a 51-year-old HIV-infected man who presented severe odynophagia and an eroded 
lesion on the hard palate that progressed to an oronasal fistula. No cutaneous lesions were 
recorded. Doxycycline led to complete resolution. To the best of our knowledge, only six 
previous cases of oral BA without tegumentary disease have been previously reported and 
none of them progressed to fistula.
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INTRODUCTION
Bartonella are arthropod-borne pathogens that are highly adapted to their 
respective mammalian reservoir hosts. Their persistence in the bloodstream may 
occur as a result of intraerythrocytic infection. The genus is named after the Peruvian 
microbiologist Alberto Leonardo Barton, who described these organisms in 1909 
while studying the agent of Oroya fever. More than 30 Bartonella spp. have been 
isolated from humans as well as from wild and domestic animals1. Two species are 
human-specific: Bartonella bacilliformis, the agent of Oroya fever, and B. quintana, 
the agent of trench fever. Incidental zoonotic human infection by other species will 
not lead to intraerythrocytic bacteremia, but may be associated with a wide spectrum 
of clinical disorders, such as cat-scratch disease, blood culture-negative endocarditis, 
peliosis hepatis, and Parinaud oculoglandular syndrome. Most human infections are 
caused by three species: B. henselae, B. quintana and B. bacilliformis1.
Bacillary angiomatosis (BA), also called epithelioid angiomatosis, is an 
angioproliferative disease of immunocompromised patients, mainly HIV-infected 
subjects with severe CD4 cell depletion. It was first described in 1983 by Stoler et 
al.2. BA is caused by chronic infection with either B. henselae or B. quintana. Cats 
are the primary reservoir for B. henselae and the infection is transmitted to humans 
via scratches or bites of infected animals. Among cats, B. henselae is transmitted by 
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cat fleas (Ctenocephalides felis). By contrast, B. quintana 
is a human-specific pathogen with worldwide distribution 
and is transmitted by the human body louse (Pediculus 
humanus humanus).
BA usually presents with the gradual appearance of a 
few to hundreds of brown to violaceous vascular tumors 
of varying size in the skin and subcutaneous tissues. 
However, lesions may also be found in a variety of other 
tissues. Mucosal lesions may rarely occur in the oral cavity, 
pharynx, larynx, and endobronchial tissue. Therefore, 
visceral and mucosal disease should be sought in all patients 
diagnosed with cutaneous BA. 
Only a few cases of BA in the oral cavity or other 
mucosal sites have been reported. These patients generally 
have concomitant cutaneous lesions3-7. Reports of oral BA 
in patients without concomitant tegumentary disease are 
exceedingly rare8-13. We wish to report on an unusual case 
of BA without simultaneous cutaneous disease in which an 
erosive lesion progressed to an oronasal fistula.
CASE REPORT
A 51-year-old HIV-infected male patient from Rio de 
Janeiro State, Brazil, sought medical care in December 2013 
with a several week history of dysphagia and odynophagia. 
He had had a diagnosis of HIV infection in 1996 and 
was also infected with hepatitis C virus. Disseminated 
histoplasmosis was successfully treated 10 years before the 
current presentation. He was lost to follow-up several times 
between 1996 and 2013. When he first noticed the pain and 
difficulty in swallowing, the antiretroviral regimen had been 
paused for more than 8 months. At this point, the CD4 cell 
count was 316 cells/mm3. Laboratory evaluations, as well 
as chest X-ray, were unremarkable. 
Clinical examination revealed a painful bluish-purple 
papular lesion over the right palatoglossal arch. There were 
no tegumentary lesions. Antiretroviral therapy was restarted 
with a combination of lamivudine, tenofovir, atazanavir 
and ritonavir. Acyclovir was empirically prescribed for 
presumed oral herpes, with no clinical response. One 
month later the lesion was larger, extended to the hard 
palate (Figure 1), had an erosive center and progressed to 
an oronasal fistula. The patient was febrile and complained 
of severe odynophagia. Freely movable submandibular and 
cervical lymph nodes were recorded. He was admitted to the 
inpatient unit and a biopsy of the lesion was then performed 
as a diagnostic procedure. 
Histopathological studies showed lobular vascular 
proliferation with epithelioid endothelial cells and an 
intervening edematous stroma with an inflammatory infiltrate 
containing multiple neutrophils (Figures 2A and 2B). When 
stained with Warthin-Starry, nests of small, extracellular, 
dark-stained bacilli were revealed (Figure 2C). A diagnosis 
of oral BA was then made. Antimicrobial therapy with 
doxycycline 100 mg bid was immediately instituted and 
continued for 3 months. The patient rapidly improved 
during the following days and experienced an uneventful 
recovery. The oronasal fistula left minimal sequelae of 
hyperrhinolalia. Two years later, an indirect fluorescence 
assay for Bartonella spp. IgG antibodies, performed 
according to the manufacturer instructions, yielded a titer 
of 1:256, indicating a previous exposure to Bartonella spp. 
Unfortunately, a serological assay could not be performed 
at the time of hospitalization. Therefore, comparison of 
paired samples is not possible in the present case. No 
evidence of relapse was recorded after more than three 
years of follow-up.
DISCUSSION
BA is classically associated with HIV-infection. 
However, it may also complicate the course of other 
immunosuppressive conditions14,15 and may rarely occur 
in apparently immunocompetent subjects16. Most patients 
present with cutaneous disease. In 1987, Cockerell et 
al.3 were the first to report a case of mucosal lesions 
resembling BA: a 32-year-old HIV-infected male who had 
numerous cutaneous lesions and died from asphyxiation 
due to laryngeal obstruction by multiple angiomata. 
However, no histopathological examination was available 
from the laryngeal lesions. Similar reports of mucosal 
lesions in patients with simultaneous cutaneous BA 
followed4-6. Speight et al.8 were the first to report a 
case of histopathologically-proven mucosal BA. Their 
Figure 1 - Clinical image of a 51-year-old HIV-infected male 
patient who presented with a several week history of dysphagia 
and odynophagia. A painful bluish-purple papular lesion with 
an erosive center-on the right palatoglossal arch is seen. The 
lesion was very painful
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patient presented with BA confined to the oral cavity and, 
interestingly, had no associated cutaneous lesions. Few 
other reports of oral BA with7 or without simultaneous 
cutaneous lesions9,10-13 followed. Isolated reports of BA in 
other gastrointestinal mucosal sites, with17,18 or without19,20 
simultaneous cutaneous disease, are also available.
The differential diagnosis of BA includes Kaposi`s 
sarcoma (KS), pyogenic granuloma, hemangioma, 
angiosarcoma, and cat scratch disease. It shares 
histopathological resemblance with KS, pyogenic 
granuloma, verruga peruana and angiosarcoma. The 
histopathological hallmark of BA is the presence of lobular 
proliferations of blood vessels, neutrophilic infiltration, and 
interstitial amorphous granular-like deposits that reveal 
small, extracellular, argyrophilic bacilli when stained with 
Warthin-Starry silver. In contrast, Kaposi’s sarcoma lesions 
show slit-like vascular spaces with lymphoplasmacytic 
inflammation and no bacilli can be stained. It should 
be stressed that even in patients who have a confirmed 
diagnosis of cutaneous KS, careful histopathological 
examination of mucosal lesions should be performed. López 
de Blanc et al.11 described a patient in whom the cutaneous 
lesions were KS, but the oral lesions were BA. Therefore, 
the presence of confirmed cutaneous KS lesions should 
not be taken as evidence that the oral lesions are also KS.
Oral BA in HIV-infected patients is highly unusual 
but oral BA in patients without simultaneous cutaneous 
disease is even rarer. To the best of our knowledge, only 
six previous cases of oral BA without tegumentary disease 
have been reported to date8-13. All but one of these12 were 
from the pre-highly active antiretroviral therapy era. Our 
patient presented with a painful bluish-purple papular lesion 
that eroded in the right palate and progressed to an oronasal 
fistula within days. A review of the clinical presentation of 
the few reported cases of oral BA shows that the lesions 
may be painful9,10, eroded8,11, associated with alveolar bone 
loss9,11 and may relapse after inappropriate treatment8,12. 
They may present as sessile or lobulated swellings11, 
nodules10 or simply as a raised lesion8. The lesions may 
bleed after oral hygiene12, have a red to bluish9 or flat 
blue8 aspect resembling KS. Gums and palate seem to be 
the preferred sites.
In summary, physicians caring for HIV-infected 
patients should be aware that BA may unusually present 
with lesions in the oral cavity or other mucosal sites, even 
in patients with no concomitant tegumentary disease. 
Figure 2 - A) Low power (original magnification 10x) hematoxylin and eosin stain shows neutrophilic inflammation and capillary 
proliferation; B) lobular vascular proliferation with epithelioid endothelial cells and an intervening edematous stroma with an 
inflammatory infiltrate of multiple neutrophils (original magnification 20x); C) Clumps of small extracellular, argyrophilic bacilli as 
unveiled by Warthin-Starry silver stain (original magnification 40x)
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These lesions may be highly painful and eroded and will 
require biopsy and appropriate histopathological studies 
to be differentiated from other disorders such as KS. 
Recovery is usually straightforward when appropriate 
antimicrobial therapy is initiated. Timely diagnosis is of 
utmost importance since this treatable infectious disorder 
may rapidly progress.
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